Astrazeneca

FromAstraZeneca ([email protected])
Subject (45)Imfinzi approved in the EU for bladder cancer
Preheader (107)Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Typography
Arial
Colors
Text Analysis
Body Words132
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning

Imfinzi approved in the EU for bladder cancer

Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Imfinzi approved in the EU for bladder cancer